Evotec, a pharmaceutical company, has entered into a multiple target drug discovery collaboration with Shionogi & Co to identify small molecule modulators of various protein-protein interaction targets.
44921
Evotec enters into drug discovery collaboration with Shionogi
94470
Thousands of cancer patients to benefit from new drug
154417
Lloydspharmacy launches co-branded generics
88480
Mayo Clinic partnership to advance personalized medicine
133627
Momentive Specialty Chemicals to sell business
115525
IMedicor signs agreement with Access Pharmaceuticals for the North American commercial launch of MuGard
82081
Estée Lauder brand breaks new ground in skincare science
100109
InVivo Therapeutics announces business updates
105963
Lancaster Laboratories collaborates with BioAzure
110203
A mysterious form of cell death uncovers prime suspect for new cancer drug development
16779
Researchers create new green method for developing medicines
110579
Scientists harness new drug discovery tool to treat diabetes
95911
Sanofi-Aventis to acquire Genzyme?
108482
Regulatory, commercial considerations are the primary drivers for biosimilar development
65235
How two proteins fuse together to trigger cancer
73557
Obesity drug sails through trials
175596
Compugen discovers cancer treatment target